RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists.

Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists.

Add to Collection
2017 Jun Review Fist_Author_Year_PM

Full Author : ['Singh, Awadhesh Kumar', 'Singh, Ritu']
Journal Title : Expert review of clinical pharmacology
Chapter : Section3
Journal Year : 2017
Cited by : Not Available

Both sodium-glucose co-transporter-2 inhibitors (SGLT-2Is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been consistently found to lower blood glucose, body weight and systolic blood pressure (SBP) in patients with type 2 diabetes mellitu.....

Keywords : ["longacte receptor agonist", "indirect comparison", "canagliflozin review", "spotlight", "inhibitor", "efficacy"]